The digital branding company cut the size of its shares prior to flotation, only to see the price rise after it went public.

The SingTel-backed digital advertising company has cut the range of its forthcoming initial public offering from $11-$13 to $7-$8.

Internet portal Naver is set to reap a huge return as its messaging app subsidiary files for an initial public offering that values it at almost $10bn.

The pharmaceutical company, which has Novo as its third largest shareholder, will seek to raise up to $86.3m.

The Yaskawa-backed motorised prosthesis maker intends to invest the proceeds on expanding marketing and beginning work on the next generation of its technology.

The Tencent and Legend-backed company, which claims to be China's largest mobile game publisher, will earmark some of the proceeds for acquisitions.

The pharmaceutical company raised $32.7m after floating at a price far below its range, while Janssen Pharmaceutica took a 17% stake.

The Novo Nordisk-backed cancer drug developer has set a $75m target for its initial public offering and will use the proceeds to fund further research.

The healthcare data security system provider has gone public, but at a price considerably below its $115m target.